139 related articles for article (PubMed ID: 35612583)
1. PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.
Yang Z; Tian H; Li L; Li C; Xu J; Bie F; Chen Y; Tian Y; Bai G; Peng Y; Yang J; Fan T; Xiao C; Liu W; Liu L; Li R; Sun S; Zheng B; Tan F; Ying J; Li C; Gao S; He J
Int J Cancer; 2022 Sep; 151(5):717-729. PubMed ID: 35612583
[TBL] [Abstract][Full Text] [Related]
2. The Correlation Between Histologic, Immunophenotypic, and Molecular Characteristics of Pulmonary Sarcomatoid Carcinoma Reveals That Sarcomatoid Change Is Potentially Derived From Epithelial Carcinoma Cells Undergoing Epithelial-Mesenchymal Transition.
Huang Y; Guo J; Li S; Liu J; Xu J; Ye W; Zhang L; Dong Z; Wu W; Wu C; Hou L
Appl Immunohistochem Mol Morphol; 2023 Jan; 31(1):17-25. PubMed ID: 36165833
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
[TBL] [Abstract][Full Text] [Related]
4. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category.
Walia R; Jain D; Madan K; Sharma MC; Mathur SR; Mohan A; Iyer VK; Kumar L
Indian J Med Res; 2017 Jul; 146(1):42-48. PubMed ID: 29168459
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical detection by a fully automated immunostainer for assisting subclassification of pulmonary tumors on ThinPrep slides in real-life clinical samples: A single-institution experience.
Zhao L; Ma H; Sun Y; Wang C; Chang X; Guo H; Zhao H; Zhang Z
Diagn Cytopathol; 2023 Jun; 51(6):365-373. PubMed ID: 36905334
[TBL] [Abstract][Full Text] [Related]
7. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40.
Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T
Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Yvorel V; Patoir A; Casteillo F; Tissot C; Fournel P; Stachowicz ML; Karpathiou G; Tiffet O; Péoc'h M; Forest F
PLoS One; 2017; 12(7):e0180346. PubMed ID: 28671973
[TBL] [Abstract][Full Text] [Related]
10. Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8
Zhang C; Li Z; Zhang Y; Zhao C; Wang H; Lin J; Liu C; Wang X; Wang H
Int J Gen Med; 2022; 15():4209-4220. PubMed ID: 35480996
[TBL] [Abstract][Full Text] [Related]
11. Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Ota T; Kirita K; Matsuzawa R; Udagawa H; Matsumoto S; Yoh K; Niho S; Ishii G; Goto K
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2495-2506. PubMed ID: 31494736
[TBL] [Abstract][Full Text] [Related]
12. Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma.
Baldovini C; Rossi G; Ciarrocchi A
Lung Cancer (Auckl); 2019; 10():131-149. PubMed ID: 31824199
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
Terada K; Menju T; Date H; Haga H; Yoshizawa A
Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
[TBL] [Abstract][Full Text] [Related]
14. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC
Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805
[TBL] [Abstract][Full Text] [Related]
15. Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.
Ilie M; Beaulande M; Hamila M; Erb G; Hofman V; Hofman P
Lung Cancer; 2018 Oct; 124():90-94. PubMed ID: 30268486
[TBL] [Abstract][Full Text] [Related]
16. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
17. Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.
Yang Z; Xu J; Li L; Li R; Wang Y; Tian Y; Guo W; Wang Z; Tan F; Ying J; Jiao Y; Gao S; Wang J; Gao Y; He J
Nat Commun; 2020 Sep; 11(1):4878. PubMed ID: 32985499
[TBL] [Abstract][Full Text] [Related]
18. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
[TBL] [Abstract][Full Text] [Related]
19. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
Shen E; Xiu J; Bentley R; López GY; Walsh KM
Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
[TBL] [Abstract][Full Text] [Related]
20. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
